Literature DB >> 7745713

Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus.

I H Chen1, C J Huang, L P Ting.   

Abstract

The regulation of transcription of the hepatitis B virus core promoter is an important event in the viral life cycle. Two messages, precore and pregenomic RNAs, that are initiated 30 nucleotides apart are produced by the core promoter. Precore RNA encodes nucleocapsid protein and pregenomic RNA core and polymerase. The latter transcript also serves as a template for viral genome replication via reverse transcription. We have previously defined a basal core promoter, which contains four TA-rich sequences (TA1 through TA4) but no canonical TATA element, that can direct transcription of both messages. In this study, we demonstrated that a stretch of 15 nucleotides containing TA4 is sufficient to direct precise initiation of both precore and pregenomic transcripts. This sequence can function as both an initiator and a TATA element. Mutational analysis further revealed that sequences essential for either function are colocalized. The significance of this finding with respect to the basal transcription mechanism and regulation of viral gene expression is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745713      PMCID: PMC189080          DOI: 10.1128/JVI.69.6.3647-3657.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF.

Authors:  A L Roy; M Meisterernst; P Pognonec; R G Roeder
Journal:  Nature       Date:  1991-11-21       Impact factor: 49.962

Review 2.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

4.  Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

Authors:  J Honigwachs; O Faktor; R Dikstein; Y Shaul; O Laub
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  The "initiator" as a transcription control element.

Authors:  S T Smale; D Baltimore
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

6.  Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Authors:  R P Beasley; L Y Hwang; C C Lin; C S Chien
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

7.  Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

Authors:  K Yaginuma; Y Shirakata; M Kobayashi; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

Review 9.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

10.  Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line.

Authors:  C M Chang; K S Jeng; C P Hu; S J Lo; T S Su; L P Ting; C K Chou; S H Han; E Pfaff; J Salfeld
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  23 in total

1.  Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction.

Authors:  M Nakanishi-Matsui; Y Hayashi; Y Kitamura; K Koike
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis.

Authors:  Farzaneh Salarnia; Sima Besharat; Sare Zhand; Naeme Javid; Behnaz Khodabakhshi; Abdolvahab Moradi
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Authors:  H Ishida; K Ueda; K Ohkawa; Y Kanazawa; A Hosui; F Nakanishi; E Mita; A Kasahara; Y Sasaki; M Hori; N Hayashi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  A composite polyadenylation signal with TATA box function.

Authors:  N Paran; A Ori; I Haviv; Y Shaul
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  In vivo regulation of hepatitis B virus replication by peroxisome proliferators.

Authors:  L G Guidotti; C M Eggers; A K Raney; S Y Chi; J M Peters; F J Gonzalez; A McLachlan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  A revised secondary structure model for the 3'-end of hepatitis B virus pregenomic RNA.

Authors:  A H Kidd; K Kidd-Ljunggren
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

Review 8.  Core promoter: a critical region where the hepatitis B virus makes decisions.

Authors:  Jorge Quarleri
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation.

Authors:  J Li; V E Buckwold; M W Hon; J H Ou
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.

Authors:  Kuen-Nan Tsai; Chin-Liew Chong; Yu-Chi Chou; Chien-Chiao Huang; Yi-Ling Wang; Shao-Win Wang; Mong-Liang Chen; Chun-Hong Chen; Chungming Chang
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.